US biotech Cogent Biosciences (Nasdaq: COGT) has seen its share price more than double after its lead drug, bezuclastinib, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback